Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling.

MLA

Chen, Chen, et al. “Identification of a Novel PHGDH Covalent Inhibitor by Chemical Proteomics and Phenotypic Profiling.” Acta Pharmaceutica Sinica. B, vol. 12, no. 1, Jan. 2022, pp. 246–61. EBSCOhost, https://doi.org/10.1016/j.apsb.2021.06.008.

APA

Chen, C., Zhu, T., Liu, X., Zhu, D., Zhang, Y., Wu, S., Han, C., Zhang, H., Luo, J., & Kong, L. (2022). Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling. Acta Pharmaceutica Sinica. B, 12(1), 246–261. https://doi.org/10.1016/j.apsb.2021.06.008

Chicago

Chen, Chen, Tianyu Zhu, Xiaoqin Liu, Dongrong Zhu, Yi Zhang, Sifang Wu, Chao Han, Hao Zhang, Jianguang Luo, and Lingyi Kong. 2022. “Identification of a Novel PHGDH Covalent Inhibitor by Chemical Proteomics and Phenotypic Profiling.” Acta Pharmaceutica Sinica. B 12 (1): 246–61. doi:10.1016/j.apsb.2021.06.008.